Virtual symposium of experts on the occasion of the official launch of the new medicinal product Kaftrio (R) (ivacaftor / tezakaftor / elexacaftor) on the market in the Czech Republic

Abstract

On March 4, 2021, Vertex Pharmaceuticals organized an online symposium for cystic fibrosis (CF) specialists in the Czech Republic, with the aim of officially launching Kaftrio(R) (ivacaftor / tezakaftor / elexacaftor) on the domestic market. The invitation was accepted by almost all doctors who deal with cystic fibrosis patients, a total of 35 participants registered.

Keywords

• Kaftrio®
• ivacaftor
• thezacaftor, elexacaftor
• cystic fibrosis